Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
Holding WST?
Track your performance easily
Earnings Data
Report Date
Feb 13, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
1.72Last Year’s EPS
1.83Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 25, 2018
|% Change Since: 17.49%
|Next Earnings Date:Jul 26, 2018
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance for West Pharmaceutical, with strong revenue performance and strategic positioning in high-growth areas like biologics and contract manufacturing. However, the company faces challenges with organic sales decline, margin reductions, and ongoing destocking issues. Despite these challenges, increased guidance for adjusted EPS and strategic investments in growth areas provide a positive outlook.Company Guidance
During the Q3 2024 earnings call for West Pharmaceutical Services, the company provided updated financial guidance, reflecting an increase in full-year adjusted EPS to a range of $6.55 to $6.75 from the prior range of $6.35 to $6.65. This adjustment was supported by a solid quarterly performance, with net sales reaching $746.9 million, marking an organic sales decline of 0.5%. The adjusted operating profit margin was reported at 21.5%, a decrease of 270 basis points from the previous year, while adjusted diluted EPS declined by 14.4%. The company also highlighted a $19 million customer incentive associated with achieving volume levels, impacting the sales price positively by $34.2 million or 4.6 percentage points, despite a negative volume and mix impact of $37.6 million. Looking ahead, West Pharmaceutical Services anticipates full-year net sales between $2.875 billion and $2.905 billion, with an expected organic sales decline of 1.5% to 2%, and maintained its CapEx guidance at $375 million.Solid Q3 Performance and Revenue Increase
West Pharmaceutical reported Q3 revenues of $746.9 million, at the higher end of expectations, and increased full-year net sales guidance to $2.875 billion to $2.905 billion.
Strong Position in Biologics and New Drug Launches
West continues to hold a strong position in the biologics segment, with high participation in new drug launches and ongoing improvements in self-injection devices.
Contract Manufacturing Margin Improvement
Contract Manufacturing segment gross profit margin increased by 130 basis points compared to Q3 2023 due to production efficiencies.
Adjusted EPS Guidance Increase
Full-year 2024 adjusted diluted EPS guidance raised to $6.55 to $6.75 from $6.35 to $6.65.
---
WST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
WST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 24, 2024 | $286.26 | $330.44 | +15.43% |
| Jul 25, 2024 | $323.35 | $276.80 | -14.40% |
| Apr 25, 2024 | $385.22 | $367.70 | -4.55% |
| Feb 15, 2024 | $407.44 | $350.05 | -14.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does West Pharmaceutical Services, Inc. (WST) report earnings?
West Pharmaceutical Services, Inc. (WST) is schdueled to report earning on Feb 13, 2025, TBA Not Confirmed.
What is West Pharmaceutical Services, Inc. (WST) earnings time?
West Pharmaceutical Services, Inc. (WST) earnings time is at Feb 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WST EPS forecast?
WST EPS forecast for the fiscal quarter 2024 (Q4) is 1.72.
---
